Last reviewed · How we verify

NCT05725395

Virtual Reality as a Intrinsic Motivation Intervention

Completed NA Last updated 4 November 2025
What this trial tests

NA trial testing Virtual Reality in Psychological in 158 participants. Completed in 30 January 2025.

Timeline
20 June 2023
Primary endpoint
30 January 2025
30 January 2025

Quick facts

Lead sponsorThomas Caruso
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Enrollment158
Start date20 June 2023
Primary completion30 January 2025
Estimated completion30 January 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Thomas Caruso

Who can join

Adults 5 to 25, any sex, with Psychological. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal is to explore the use of Virtual Reality (VR) as an intervention to increase intrinsic motivation in a healthcare setting. The investigators would like to determine if an educational VR intervention in the course of healthcare could increase pediatric patient intrinsic motivation compared to standard of care (i.e no VR).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual Reality

Trials testing the same drug.

Other recruiting trials for Psychological

Currently open trials in the same condition.

Other Thomas Caruso trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05725395.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing